Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the successful ...

Luma Vision announced today that it expanded its clinical program following the latest submission of its Verafeye platform to ...

LUMA Vision, a leader in cardiac 4D imaging and navigation, today announces the expansion of its clinical program with the first patient enrolments in ...

Turco, an interventional cardiologist, has held roles including CEO of JC Medical and chief medical officer of Medtronic’s aortic and peripheral vascular business.

Pulse Biosciences (Nasdaq:PLSE) announced a new strategic alignment to focus on its nPulse cardiac catheter ablation system.

Pulsed field ablation allows us to treat AFib in a way that is minimally invasive, efficient and designed to enhance ...

Medtronic's key catalysts, including Symplicity Spyral, PFA, and Hugo, have promising growth ahead. Click here to read an ...

Dr. Michael J. Hushion, an electrophysiology specialist at Prairie Cardiovascular in O’Fallon, Ill., is helping bring new hope to patients living with Atrial Fibrillation (AFib), ...

Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This incorporation represents a ...

Field Medical, Inc., a clinical-stage medical technology company advancing second-generation pulsed field ablation (PFA) ...

ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera(TM) Mapping and Ablation System with Sphere-9(TM) Catheter in ambulatory surgery ...

ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera™ Mapping and Ablation System with Sphere-9™ Catheter in ambulatory surgery centers ...